Assessing the Nutrient Status of Low Carbohydrate, High-Fat (LCHF) Meal Plans in Children: A Hypothetical Case Study Design.
Caryn Zinn, Kayla-Anne Lenferna De La Motte, Amy Rush...
https://pubmed.ncbi.nlm.nih.gov/35458160/Actively Recruiting
Led by Yang Tao · Updated on 2026-04-20
80
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are studying the effect of changes in carbohydrate intake on blood glucose control in adults with type 1 diabetes. This study aims to explore whether adjusting dietary patterns can improve glucose levels and understand the related biological mechanisms, including effects on the gut environment, immune function, and metabolism. The study focuses on patients who rely on insulin therapy and have stable treatment plans. Participants are randomly assigned to one of two diet groups a diverse carbohydrate diet where carbohydrates account for 45-55% of total energy with nearly equal parts from refined and whole grainsbeans, or a moderate carbohydrate diet with 45-55% carbohydrates mostly coming from refined grains. Both diets distribute energy intake over three meals daily with specific proportions for breakfast, lunch, and dinner. During the study, participants will be monitored over 14 weeks with measurements including time in range TIR for blood glucose, glucose variability indices, HbA1c, insulin dose changes, and hypoglycemia events. Researchers will also evaluate changes in gut microbiota, metabolomics, and immune markers. Various blood tests and assessments will be conducted from baseline to 2 weeks and 14 weeks to track the impact of the dietary interventions.
CONDITIONS
Effect of Changes in Carbohydrate Intake Patterns on Glucose Control in Patients With Type 1 Diabetes
T
Tao Yang, MD/PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Yang Tao
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 14 weeks
Participants follow assigned carbohydrate intake patterns to evaluate effects on glucose control.
Regular visits during the 14-week treatment period
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Caryn Zinn, Kayla-Anne Lenferna De La Motte, Amy Rush...
https://pubmed.ncbi.nlm.nih.gov/35458160/Joseph G Hollowell, Norman W Staehling, W Dana Flanders...
https://pubmed.ncbi.nlm.nih.gov/11836274/Jessica L Turton, Ron Raab, Kieron B Rooney
https://pubmed.ncbi.nlm.nih.gov/29596460/Xiaodan Zhai, Le Zhang, Lulu Chen...
https://pubmed.ncbi.nlm.nih.gov/30351201/Preeti Kanikarla-Marie, Sushil K Jain
https://pubmed.ncbi.nlm.nih.gov/27036365/Agnieszka Lejk, Jędrzej Chrzanowski, Adrianna Cieślak...
https://pubmed.ncbi.nlm.nih.gov/34836071/Arkadiusz Dąbek, Martyna Wojtala, Luciano Pirola...
https://pubmed.ncbi.nlm.nih.gov/32192146/Sara B Seidelmann, Brian Claggett, Susan Cheng...
https://pubmed.ncbi.nlm.nih.gov/30122560/Amy L Clark, Zihan Yan, Sophia X Chen...
https://pubmed.ncbi.nlm.nih.gov/34212475/Lindsay M Jaacks, Jamie Crandell, Michelle A Mendez...
https://pubmed.ncbi.nlm.nih.gov/25630525/Yang Tao
Lead Sponsor